Macrocyclic peptidomimetic protease inhibitor and use thereof
US-2024327458-A1 · Oct 3, 2024 · US
US9487535B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9487535-B2 |
| Application number | US-201313794147-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2013 |
| Priority date | Apr 12, 2012 |
| Publication date | Nov 8, 2016 |
| Grant date | Nov 8, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Opening claim text (preview).
What is claimed is: 1. A method of preparing a compound of formula (I): as an isolated (S)-enantiomer, or a non-racemic mixture of enantiomers having an enantiomeric excess of the (S)-enantiomer of greater than 80%, or a pharmaceutically acceptable salt thereof; wherein: p and r are each independently 1, 2, 3 or 4; R 1 is hydrogen, alkyl, alkenyl,…
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.